Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis

被引:62
作者
Calandra, T [1 ]
Froidevaux, W [1 ]
Martin, C [1 ]
Roger, T [1 ]
机构
[1] CHU Vaudois, Dept Internal Med, Div Infect Dis, CH-1011 Lausanne, Switzerland
关键词
D O I
10.1086/374752
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Macrophages are essential effector cells of innate immunity that play a pivotal role in the recognition and elimination of invasive microorganisms. Mediators released by activated macrophages orchestrate innate and adaptive immune host responses. The cytokine macrophage migration inhibitory factor (MIF) is an integral mediator of the innate immune system. Monocytes and macrophages constitutively express large amounts of MIF, which is rapidly released after exposure to bacterial toxins and cytokines. MIF exerts potent proinflammatory activities and is an important cytokine of septic shock. Recent investigations of the mechanisms by which MIF regulates innate immune responses to endotoxin and gram-negative bacteria indicate that MIF acts by modulating the expression of Toll-like receptor 4, the signal-transducing molecule of the lipopolysaccharide receptor complex. Given its role in innate immune responses to bacterial infections, MIF is a novel target for therapeutic intervention in patients with septic shock.
引用
收藏
页码:S385 / S390
页数:6
相关论文
共 49 条
  • [1] An essential regulatory role for macrophage migration inhibitory factor in T-cell activation
    Bacher, M
    Metz, CN
    Calandra, T
    Mayer, K
    Chesney, J
    Lohoff, M
    Gemsa, D
    Donnelly, T
    Bucala, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) : 7849 - 7854
  • [2] Bacher M, 1997, AM J PATHOL, V150, P235
  • [3] Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness
    Beishuizen, A
    Thijs, LG
    Haanen, C
    Vermes, I
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (06) : 2811 - 2816
  • [4] Biochemical and nutational investigations of the enzymatic activity of macrophage migration inhibitory factor
    Bendrat, K
    AlAbed, Y
    Callaway, DJE
    Peng, T
    Calandra, T
    Metz, CN
    Bucala, R
    [J]. BIOCHEMISTRY, 1997, 36 (49) : 15356 - 15362
  • [5] MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA
    BERNHAGEN, J
    CALANDRA, T
    MITCHELL, RA
    MARTIN, SB
    TRACEY, KJ
    VOELTER, W
    MANOGUE, KR
    CERAMI, A
    BUCALA, R
    [J]. NATURE, 1993, 365 (6448) : 756 - 759
  • [6] PURIFICATION, BIOACTIVITY, AND SECONDARY STRUCTURE-ANALYSIS OF MOUSE AND HUMAN MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF)
    BERNHAGEN, J
    MITCHELL, RA
    CALANDRA, T
    VOELTER, W
    CERAMI, A
    BUCALA, R
    [J]. BIOCHEMISTRY, 1994, 33 (47) : 14144 - 14155
  • [7] MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY
    BLOOM, BR
    BENNETT, B
    [J]. SCIENCE, 1966, 153 (3731) : 80 - &
  • [8] STRUCTURAL CHARACTERIZATION AND CHROMOSOMAL LOCATION OF THE MOUSE MACROPHAGE-MIGRATION INHIBITORY FACTOR GENE AND PSEUDOGENES
    BOZZA, M
    KOLAKOWSKI, LF
    JENKINS, NA
    GILBERT, DJ
    COPELAND, NG
    DAVID, JR
    GERARD, C
    [J]. GENOMICS, 1995, 27 (03) : 412 - 419
  • [9] Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis
    Bozza, M
    Satoskar, AR
    Lin, GS
    Lu, B
    Humbles, AA
    Gerard, C
    David, JR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (02) : 341 - 346
  • [10] MACROPHAGE IS AN IMPORTANT AND PREVIOUSLY UNRECOGNIZED SOURCE OF MACROPHAGE-MIGRATION INHIBITORY FACTOR
    CALANDRA, T
    BERNHAGEN, J
    MITCHELL, RA
    BUCALA, R
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (06) : 1895 - 1902